Thursday, October 31, 2019 5:15:54 PM
"Discovery Harbour Resources Corp. (TSXV: DHR) ("Discovery Harbour" or the "Company") is pleased to announce that, further to its news releases of October 9, 2019 and October 23, 2019, the Company has closed the final tranche of its non-brokered private placement (the "Offering") to raise additional gross proceeds of $205,800 (the "Final Tranche") through the sale of a further 4,116,000 units priced at $0.05 per unit (each, a "Unit"). Each Unit consists of one common share (each, a "Share") and one share purchase warrant (each, a "Warrant") exercisable into one further Share at a price of $0.10 for a term of one year, subject to an acceleration provision of the Company whereby, if for any ten (10) consecutive trading days the closing price of the Shares on the TSX Venture Exchange exceeds $0.20 at any time commencing four (4) months after the Closing and until there expiry date, than the remaining term of the Warrants will be reduced to thirty (30) days, commencing seven (7) days from the end of such ten (10) consecutive trading day period.
All securities issued in the Final Tranche are subject to a four month hold period expiring March 1, 2020. No finder's fees were paid in the Final Tranche.
The proceeds from the Offering will be used for property payments and exploration costs on the Company's 100% optioned Caldera project and for general working capital.
The Final Tranche completes the Company's Offering to raise a total of $600,000 through the sale of 12,000,000 units. The Offering was oversubscribed and units were allocated amongst subscribers on a pro-rata basis. Mark Fields, the Company's President, remarks, "We are pleased that we were able to accommodate everyone who expressed an interest in the financing. We would like to thank our supporting investors including Richard Gilliam, Salman Capital Inc., and other key participants."
Richard Gilliam, a director of the Company, subscribed for a total of 4,000,000 Units in the Offering. Mr. Gilliam is considered a "related party" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") and the Offering is therefore considered to be a "related party transaction" within the meaning of MI 61-101. The Offering, however, is exempt from the valuation requirement of MI 61-101 by virtue of the exemption contained in section 5.5(b) as the Company's shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101 in that the fair market value of the consideration of the units issued to the related party did not exceed 25% of the Company's market capitalization.
Recent DHR News
- Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry • PR Newswire (US) • 05/03/2024 01:06:00 PM
- Danaher Reports First Quarter 2024 Results • PR Newswire (US) • 04/23/2024 10:00:00 AM
- Danaher Schedules First Quarter 2024 Earnings Conference Call • PR Newswire (US) • 03/21/2024 08:15:00 PM
- Danaher to Present at TD Cowen Health Care Conference • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets • PR Newswire (US) • 02/22/2024 09:15:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 02/21/2024 09:15:00 PM
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development • PR Newswire (US) • 02/05/2024 12:30:00 PM
- Danaher Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (US) • 01/30/2024 11:00:00 AM
- Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution • PR Newswire (US) • 01/09/2024 12:30:00 PM
- Danaher Says 4Q Adjusted. Revenue to Fall by Less Than Forecast • Dow Jones News • 01/08/2024 09:57:00 PM
- Danaher CEO to Comment on Financial Performance • PR Newswire (US) • 01/08/2024 09:15:00 PM
- Danaher to Present at J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/02/2024 10:00:00 PM
- Danaher Schedules Fourth Quarter 2023 Earnings Conference Call • PR Newswire (US) • 12/21/2023 09:30:00 PM
- Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase • GlobeNewswire Inc. • 12/13/2023 09:06:00 PM
- Danaher Completes Acquisition of Abcam • PR Newswire (US) • 12/06/2023 12:30:00 PM
- Danaher Cuts Quarterly Dividend to 24 Cents • Dow Jones News • 12/05/2023 10:14:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 12/05/2023 09:30:00 PM
- Danaher to Present at Evercore ISI HealthCONx Conference • PR Newswire (US) • 11/21/2023 09:15:00 PM
- Danaher on Track for Largest Percent Increase in Almost a Year -- Data Talk • Dow Jones News • 11/21/2023 07:22:00 PM
- Danaher appoints Christopher Riley to Executive Vice President for Biotechnology • PR Newswire (US) • 10/31/2023 11:30:00 AM
- Danaher 3Q Earnings, Sales Decline but Beat Estimates • Dow Jones News • 10/24/2023 10:41:00 AM
- Danaher Reports Third Quarter 2023 Results • PR Newswire (US) • 10/24/2023 10:00:00 AM
- Keep An Eye Out: Pre-Market Movers And Analyst Recommendations • IH Market News • 10/17/2023 10:34:10 AM
- Danaher Corporation Completes Separation of Veralto Corporation • PR Newswire (US) • 09/30/2023 12:00:00 PM
- Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600 • PR Newswire (US) • 09/28/2023 10:17:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM